We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

BellBrook Labs Launches Methyltransferase Assay to Accelerate Epigenetic Drug Discovery

Product News   Aug 14, 2017

 
BellBrook Labs Launches Methyltransferase Assay to Accelerate Epigenetic Drug Discovery

Methyltransferases have become a major focus of drug discovery for cancer and other diseases driven by epigenetic factors. BellBrook Labs’ new, ultra-sensitive AptaFluor™ SAH Methyltransferase Assay eliminates cost and sensitivity barriers that are slowing the discovery of methyltransferase inhibitors. Credit: BellBrook Labs

 
 
FURTHER INFORMATION
 
 
 

Related Product News

Peli BioThermal Announces Availability of its New CoolPall™ Flex Bulk Shipper System

Product News

Peli BioThermal, the global name in temperature controlled packaging, has announced production of its newest addition to its range of bulk shippers, the CoolPall™ Flex, which is now available to purchase for the first time.

READ MORE

Owlstone Medical Appoints Five Leading Experts to Scientific Advisory Board

Product News

Additions form a key strategic resource to advise on Breath Biopsy platform, product, and study development.

READ MORE

Steve Yemm Appointed CEO of Labguru’s, BioData

Product News

BioData has announced the appointment of Steve Yemm as CEO, following a decade of growth in the adoption of its flagship product Labguru.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Genomics Research Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE